FDA clears Elscint CardiaL gamma camera

Article

Elscint has begun shippingits Apex SPX CardiaL gamma camera after the system received Foodand Drug Administration marketing clearance in February. Elscint,of Hackensack, NJ, displayed the camera at the American Collegeof Cardiology meeting in Atlanta

Elscint has begun shippingits Apex SPX CardiaL gamma camera after the system received Foodand Drug Administration marketing clearance in February. Elscint,of Hackensack, NJ, displayed the camera at the American Collegeof Cardiology meeting in Atlanta last month.

CardiaL is a fixed 90º-angle dual-head camera designedspecifically for cardiac imaging. The unit's heads swivel outward,allowing clinicians to perform supine SPECT imaging and then uprightstress testing immediately afterward.

CardiaL was introduced at the Society of Nuclear Medicine meetinglast year (SCAN 6/30/93). The system will be Elscint's main cardiacgamma camera. There are two installations of CardiaL and six moresystems on order, according to the company.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.